Progyny Raises FY2026 Adjusted EPS and Sales Guidance

Progyny raised FY2026 adjusted EPS guidance from $2.04-$2.10 to $2.09-$2.13 and sales guidance from $1.360B-$1.385B to $1.365B-$1.385B. The headline lists estimates of $1.28 EPS and $1.373B sales.